Structure

Physi-Chem Properties

Molecular Weight:  446.39
Volume:  489.636
LogP:  7.159
LogD:  4.619
LogS:  -5.907
# Rotatable Bonds:  0
TPSA:  24.94
# H-Bond Aceptor:  4
# H-Bond Donor:  0
# Rings:  5
# Heavy Atoms:  4

MedChem Properties

QED Drug-Likeness Score:  0.434
Synthetic Accessibility Score:  5.487
Fsp3:  1.0
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Rejected
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Accepted
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -4.939
MDCK Permeability:  8.928156603360549e-06
Pgp-inhibitor:  0.012
Pgp-substrate:  0.962
Human Intestinal Absorption (HIA):  0.01
20% Bioavailability (F20%):  0.947
30% Bioavailability (F30%):  0.01

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.042
Plasma Protein Binding (PPB):  93.67208862304688%
Volume Distribution (VD):  0.987
Pgp-substrate:  3.8329596519470215%

ADMET: Metabolism

CYP1A2-inhibitor:  0.012
CYP1A2-substrate:  0.547
CYP2C19-inhibitor:  0.053
CYP2C19-substrate:  0.933
CYP2C9-inhibitor:  0.002
CYP2C9-substrate:  0.02
CYP2D6-inhibitor:  0.989
CYP2D6-substrate:  0.876
CYP3A4-inhibitor:  0.052
CYP3A4-substrate:  0.66

ADMET: Excretion

Clearance (CL):  3.563
Half-life (T1/2):  0.071

ADMET: Toxicity

hERG Blockers:  0.942
Human Hepatotoxicity (H-HT):  0.768
Drug-inuced Liver Injury (DILI):  0.787
AMES Toxicity:  0.178
Rat Oral Acute Toxicity:  0.037
Maximum Recommended Daily Dose:  0.413
Skin Sensitization:  0.978
Carcinogencity:  0.099
Eye Corrosion:  0.054
Eye Irritation:  0.425
Respiratory Toxicity:  0.842

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC127553

Natural Product ID:  NPC127553
Common Name*:   PQYOPBRFUUEHRC-NIVXRMQLSA-N
IUPAC Name:   n.a.
Synonyms:   (+)-Xestospongin A
Standard InCHIKey:  PQYOPBRFUUEHRC-NIVXRMQLSA-N
Standard InCHI:  InChI=1S/C28H50N2O2/c1-3-7-15-25-17-21-30-20-10-14-24(28(30)31-25)12-6-2-4-8-16-26-18-22-29-19-9-13-23(11-5-1)27(29)32-26/h23-28H,1-22H2/t23-,24-,25-,26-,27+,28+/m1/s1
SMILES:  C1CCC[C@@H]2CCCN3[C@H]2O[C@H](CCCCCC[C@H]2[C@@H]4O[C@H](CC1)CCN4CCC2)CC3
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL456076
PubChem CID:   9889796
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000002] Organoheterocyclic compounds
      • [CHEMONTID:0000195] Piperidines

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO32702 xestospongia sp. Species Petrosiidae Eukaryota n.a. n.a. n.a. PMID[11908959]
NPO32702 xestospongia sp. Species Petrosiidae Eukaryota n.a. Caledonian n.a. PMID[1453184]
NPO32702 xestospongia sp. Species Petrosiidae Eukaryota n.a. Thai n.a. PMID[14640515]
NPO32702 xestospongia sp. Species Petrosiidae Eukaryota n.a. thai n.a. PMID[15217287]
NPO32702 xestospongia sp. Species Petrosiidae Eukaryota n.a. n.a. n.a. PMID[1710256]
NPO32702 xestospongia sp. Species Petrosiidae Eukaryota n.a. coral reef habitat at a depth of approximately 20 m from the sea bed surface, at Sangalaki, Indonesia (2 04 59 N, 118 23 41 E) 1996-MAR PMID[20503979]
NPO32702 xestospongia sp. Species Petrosiidae Eukaryota n.a. Indonesia n.a. PMID[20503979]
NPO32702 xestospongia sp. Species Petrosiidae Eukaryota n.a. n.a. n.a. PMID[31260310]
NPO32702 xestospongia sp. Species Petrosiidae Eukaryota n.a. Philippine n.a. PMID[7473578]
NPO32702 xestospongia sp. Species Petrosiidae Eukaryota n.a. n.a. n.a. PMID[7798966]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT20 Organism Candida albicans Candida albicans MIC = 100.0 ug.mL-1 PMID[546089]
NPT554 Organism Candida glabrata Candida glabrata MIC = 100.0 ug.mL-1 PMID[546089]
NPT187 Organism Issatchenkia orientalis Pichia kudriavzevii MIC = 100.0 ug.mL-1 PMID[546089]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC127553 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
1.0 High Similarity NPC255050
0.8904 High Similarity NPC90839
0.8667 High Similarity NPC288415
0.8667 High Similarity NPC149908
0.8667 High Similarity NPC31313
0.8667 High Similarity NPC45906
0.8553 High Similarity NPC93630
0.8421 Intermediate Similarity NPC81006
0.7042 Intermediate Similarity NPC112398
0.6618 Remote Similarity NPC243635
0.6618 Remote Similarity NPC151004
0.6618 Remote Similarity NPC228980
0.6404 Remote Similarity NPC168017
0.6264 Remote Similarity NPC178632
0.6136 Remote Similarity NPC124359
0.5926 Remote Similarity NPC290231
0.5926 Remote Similarity NPC206241
0.5926 Remote Similarity NPC48448
0.5926 Remote Similarity NPC180401
0.5926 Remote Similarity NPC266383
0.5926 Remote Similarity NPC68043
0.5926 Remote Similarity NPC271803
0.5765 Remote Similarity NPC80447
0.5765 Remote Similarity NPC477002
0.5658 Remote Similarity NPC319991
0.5612 Remote Similarity NPC155985

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC127553 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.6618 Remote Similarity NPD1823 Approved
0.6618 Remote Similarity NPD1822 Approved
0.6618 Remote Similarity NPD1821 Approved
0.6329 Remote Similarity NPD2695 Approved
0.6329 Remote Similarity NPD2697 Approved
0.6329 Remote Similarity NPD2694 Approved
0.6329 Remote Similarity NPD2696 Approved
0.6232 Remote Similarity NPD7348 Clinical (unspecified phase)
0.6027 Remote Similarity NPD6439 Phase 3
0.6 Remote Similarity NPD8143 Approved
0.6 Remote Similarity NPD8144 Approved
0.5854 Remote Similarity NPD7535 Discontinued
0.5842 Remote Similarity NPD7912 Approved
0.5842 Remote Similarity NPD7987 Approved
0.5842 Remote Similarity NPD7986 Approved
0.5842 Remote Similarity NPD7911 Approved
0.5833 Remote Similarity NPD312 Clinical (unspecified phase)
0.5753 Remote Similarity NPD3727 Discontinued
0.5728 Remote Similarity NPD8040 Discontinued
0.5673 Remote Similarity NPD7646 Clinical (unspecified phase)
0.5673 Remote Similarity NPD7989 Approved
0.5673 Remote Similarity NPD7990 Approved

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data